Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality

Journal of Critical Care

Volumn 50, Issue , 2019, Pages 59-65

  Beumer, M C ^a   Koch, R M ^a   van Beuningen, D ^a   OudeLashof, A M ^b   van de Veerdonk, F L ^a   Kolwijck, E ^a   van der Hoeven, J G ^a   Bergmans, D C ^b   Hoedemaekers, C W E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bacterial; Co infections; Fungal; ICU admission; ICU mortality; Influenza virus; Risk factors; Viral

Indexed keywords

ADULT; AGED; ARTICLE; ASPERGILLUS FUMIGATUS; BODY MASS; CENTRAL SLEEP APNEA SYNDROME; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSPNEA; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; INFLUENZA A; INTENSIVE CARE UNIT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; NONHUMAN; POPULATION RESEARCH; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; COMORBIDITY; COMPLICATION; HOSPITALIZATION; INFLUENZA; MIDDLE AGED; MIXED INFECTION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY;

ADULT; AGED; BODY MASS INDEX; COINFECTION; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES;

EID: 85057110601     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2018.11.013     Document Type: Article

References (37)

1. McCullers, J.A., Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19:3 (2006), 571–582.
2. Metersky, M.L., Masterton, R.G., Lode, H., File, T.M. Jr., Babinchak, T., Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int. J. Infect. Dis. 16:5 (2012), e321–e331.
3. Lee, K.Y., Rhim, J.W., Kang, J.H., Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases. Med Hypotheses 76:1 (2011), 64–69.
4. Martin-Loeches, I., M, J.S., Vincent, J.L., Alvarez-Lerma, F., Bos, L.D., Sole-Violan, J., et al. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med 43:1 (2017), 48–58, 10.1007/s00134-016-4578-y Epub 2016 Oct 5.
5. Koch RM, Kox M, de Jonge MI, van der Hoeven JG, Ferwerda G, Pickkers P: Patterns in bacterial- and viral-induced immunosuppression and secondary infections in the ICU. Shock 2016.
6. Grimaldi, D., Llitjos, J.F., Pene, F., Post-infectious immune suppression: a new paradigm of severe infections. Medecine et maladies infectieuses 44:10 (2014), 455–463.
7. Wauters, J., Baar, I., Meersseman, P., Meersseman, W., Dams, K., De Paep, R., et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med 38:11 (2012), 1761–1768.
8. van de Veerdonk, F.L., Kolwijck, E., Lestrade, P.P., Hodiamont, C.J., Rijnders, B.J., van Paassen, J., et al. Influenza-Associated Aspergillosis in Critically Ill patients. Am J Respir Crit Care Med 196:4 (Aug 15 2017), 524–527.
9. Morens, D.M., Taubenberger, J.K., Fauci, A.S., Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198:7 (2008), 962–970.
10. Crum-Cianflone, N.F., Invasive aspergillosis associated with severe influenza infections. OPEN FORUM Infect. Dis., 3(3), 2016, ofw171.
11. Ajmal, S., Mahmood, M., Abu Saleh, O., Larson, J., Sohail, M.R., Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts. Infection 46:4 (2018 Aug), 555–558.
12. Palacios, G., Hornig, M., Cisterna, D., Savji, N., Bussetti, A.V., Kapoor, V., et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One, 4(12), 2009, e8540.
13. Walton, A.H., Muenzer, J.T., Rasche, D., Boomer, J.S., Sato, B., Brownstein, B.H., et al. Reactivation of multiple viruses in patients with sepsis. PLoS One, 9(2), 2014, e98819.
14. Templeton, K.E., Scheltinga, S.A., Beersma, M.F., Kroes, A.C., Claas, E.C., Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 42:4 (2004), 1564–1569.
15. Vincent, J.L., Moreno, R., Takala, J., Willatts, S., De Mendonca, A., Bruining, H., et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. on behalf of the working group on sepsis-related problems of the european society of intensive care medicine. Intensive Care Med 22:7 (1996), 707–710.
16. De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:12 (2008), 1813–1821.
17. Wiersinga, W.J., Bonten, M.J., Boersma, W.G., Jonkers, R.E., Aleva, R.M., Kullberg, B.J., et al. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Neth J Med 76:1 (2018), 4–13.
18. al WJWe: Dutch Guidelines on the Management of Community-Acquired Pneumonia in Adults, 2011.
19. Hale, B.G., Albrecht, R.A., Garcia-Sastre, A., Innate immune evasion strategies of influenza viruses. Future Microbiol 5:1 (2010), 23–41.
20. Loubet, P., Samih-Lenzi, N., Galtier, F., Vanhems, P., Loulergue, P., Duval, X., et al. Factors associated with poor outcomes among adults hospitalized for influenza in France: a three-year prospective multicenter study. J. Cli. Virol. 79 (2016), 68–73.
21. Shamsuzzaman, A.S., Gersh, B.J., Somers, V.K., Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290:14 (2003), 1906–1914.
22. Davlin, S.L., Blanton, L., Kniss, K., Mustaquim, D., Smith, S., Kramer, N., et al. Influenza activity - United States, 2015-16 season and Composition of the 2016-17 Influenza Vaccine. MMWR Morb Mortal Wkly Rep 65:22 (2016), 567–575.
23. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D et al: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014(4):CD008965.
24. Heneghan, C.J., Onakpoya, I., Jones, M.A., Doshi, P., Del Mar, C.B., Hama, R., et al. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Health Technol Assess 20:42 (2016), 1–242.
25. Klein, E.Y., Monteforte, B., Gupta, A., Jiang, W., May, L., Hsieh, Y.H., et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respi Viruses 10:5 (2016), 394–403.
26. Diavatopoulos, D.A., Short, K.R., Price, J.T., Wilksch, J.J., Brown, L.E., Briles, D.E., et al. Influenza a virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J. 24:6 (2010), 1789–1798.
27. Didierlaurent, A., Goulding, J., Patel, S., Snelgrove, R., Low, L., Bebien, M., et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 205:2 (2008), 323–329.
28. Sun, K., Metzger, D.W., Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 14:5 (2008), 558–564.
29. Garcia-Vidal, C., Barba, P., Arnan, M., Moreno, A., Ruiz-Camps, I., Gudiol, C., et al. Invasive aspergillosis complicating pandemic influenza a (H1N1) infection in severely immunocompromised patients. Clin Infect Dis 53:6 (2011), e16–e19.
30. Adalja, A.A., Sappington, P.L., Harris, S.P., Rimmele, T., Kreit, J.W., Kellum, J.A., et al. Isolation of Aspergillus in three 2009 H1N1 influenza patients. Influenza Other Respi Viruses 5:4 (2011), 225–229.
31. Hoyo-Ulloa, I., Cobos-Trigueros, N., Puig-De La Bellacasa, J., Martinez-Martinez, J.A., Influenza, A., (H1N1) complicated by invasive aspergillosis in non-severely immunocompromised patients. Enfermedades infecciosas y microbiologia clinica 30:9 (2012), 583–584.
32. Kim, S.H., Kim, M.N., Lee, S.O., Choi, S.H., Kim, Y.S., Woo, J.H., et al. Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis. Mycoses 55:2 (2012), 189–192.
33. Passouant, O., Mateu, P., Commandini, M., Brenkle, K., Just, B., Pulmonary aspergillosis in non-immunocompromised patient with acute respiratory distress syndrome during a (H1N1) infection. Annales francaises d'anesthesie et de reanimation 30:11 (2011), e75–e76.
34. Vehreschild, J.J., Brockelmann, P.J., Bangard, C., Verheyen, J., Vehreschild, M.J., Michels, G., et al. Pandemic 2009 influenza a(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. Epidemiol Infect 140:10 (2012), 1848–1852.
35. Flvd, Veerdonk, Gresnigt, M.S., Verweij, P.E., Netea, M.G., Personalized medicine in influenza: a bridge too far or the near future?. Curr Opin Pulm Med 23:3 (2017), 237–240.
36. Rodriguez, A., Diaz, E., Martin-Loeches, I., Sandiumenge, A., Canadell, L., Diaz, J.J., et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza a. J Antimicrob Chemother 66:5 (2011), 1140–1149.
37. Rice, T.W., Rubinson, L., Uyeki, T.M., Vaughn, F.L., John, B.B., Miller, R.R. 3rd, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 40:5 (2012), 1487–1498.